Clinical Trials for Multiple Sclerosis, Secondary Progressive

Find clinical trials for multiple sclerosis, secondary progressive. Discover research opportunities and treatment options in your area.

12 Active Trials Found

Showing 12 trials on this page

Page 1 of 1

Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis

NCT ID: NCT05122559

This clinical trial is investigating whether a medication called N-acetyl cysteine (NAC) can help protect the nerves in patients with progressive forms of multiple sclerosis (MS). The study will in...

Recruiting

Phase: PHASE2 Type: interventional Locations: San Francisco, California, United States

A Study of Allogeneic Hematopoietic Cell Transplantation for Primary Progressive Multiple Sclerosis

NCT ID: NCT06900192

This clinical trial is investigating a new treatment approach for adults with primary progressive multiple sclerosis (PPMS), a type of MS that leads to gradual worsening of symptoms without clear r...

Not yet recruiting

Phase: PHASE1 Type: interventional

Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)

NCT ID: NCT06526364

The Clinnova-MS trial is a study designed to learn more about Multiple Sclerosis (MS), a condition that affects the nervous system. Researchers want to understand how early signs of MS and changes ...

Recruiting

Type: observational Locations: Basel, , Switzerland

PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF

NCT ID: NCT06683612

This clinical trial is investigating a new study drug called PIPE-791, which may help treat two conditions: progressive multiple sclerosis (MS) and idiopathic pulmonary fibrosis (IPF). The main goa...

Recruiting

Phase: PHASE1 Type: interventional Locations: London, , United Kingdom

Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

NCT ID: NCT06516458

This clinical trial is focused on developing a new way to measure how well people with Multiple Sclerosis (MS) walk, called the Gait Deviation Index (GDI). The goal is to better understand and asse...

Recruiting

Type: observational Locations: Chicago, Illinois, United States

The Synergistic Effects of AIH and FES in Persons With MS

NCT ID: NCT06413602

This clinical trial is investigating the effects of two treatments—neuromuscular electrical stimulation (NMES) and a technique called active interventional hypoxia (AIH)—on individuals with relapsi...

Not yet recruiting

Phase: NA Type: interventional Locations: Chicago, Illinois, United States

Intermittent Hypoxia in Persons With Multiple Sclerosis

NCT ID: NCT06276634

This clinical trial is studying a new way to help people with multiple sclerosis (MS) become stronger by using a technique called Acute Intermittent Hypoxia (AIH). This involves briefly breathing i...

Recruiting

Phase: NA Type: interventional Locations: Chicago, Illinois, United States

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

NCT ID: NCT06390930

This clinical trial is looking at how a specific breathing technique, called Acute Intermittent Hypoxia (AIH), might improve arm and hand function in people with Multiple Sclerosis (MS). AIH involv...

Not yet recruiting

Phase: NA Type: interventional Locations: Chicago, Illinois, United States

Exercise Effects in Multiple Sclerosis

NCT ID: NCT05496881

This clinical trial is exploring how different types of exercise can impact people living with multiple sclerosis (MS). Researchers want to understand how regular exercise might help manage symptom...

Recruiting

Phase: NA Type: interventional Locations: Regina, Saskatchewan, Canada

MS-ResearchBiomarkerS

NCT ID: NCT05204459

The MS-ResearchBiomarkerS clinical trial is looking into how certain factors can predict whether someone with Multiple Sclerosis (MS) or related conditions will experience worsening disability. Res...

Recruiting

Type: observational Locations: Los Angeles, California, United States

Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).

NCT ID: NCT05961644

The CLASP-MS clinical trial is studying a medication called cladribine to see if it can help slow down the progression of non-active secondary progressive multiple sclerosis (MS). MS is a disease t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Warsaw, Mazowieckie, Poland

Motor Asymmetry in Progressive Multiple Sclerosis Patients

NCT ID: NCT04918225

This clinical trial is studying the causes of motor difficulties in patients with progressive forms of Multiple Sclerosis (MS), specifically focusing on those who have uneven strength or movement i...

Recruiting

Type: observational Locations: Rennes, , France, Marseille, , France

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions